๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 6 Weifang 2 Shandong 1
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing6 Weifang2 Shandong1
All 3 locations
Target enrolment
to

Trials with a site in Beijing

6 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion
NCT07552610Acute Ischemic Stroke, Large Vessel Occlusion, Thrombectomy, Neutrophil Extracellular Trap Formation
Xuanwu Hospital, Beijing
Not applicable
868
Weifang, Beijing
2026-06-22
Recruiting
Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion
NCT07519044Stroke, Acute Ischemic Stroke
Xuanwu Hospital, Beijing
Phase 4
868
Beijing, Shandong
2026-05-14
Recruiting
Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours
NCT07203625Acute Ischemic Stroke, Basilar Artery Occlusion
Xuanwu Hospital, Beijing
Phase 4
316
Beijing
2026-01-20
Recruiting
Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours
NCT07253181Acute Ischemic Stroke, Large Vessel Occlusion, Transportation of Patients
Xuanwu Hospital, Beijing
Phase 3
572
Beijing, Weifang
2026-01-06
Recruiting
Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion
NCT05779215Acute Ischemic Stroke
Xuanwu Hospital, Beijing
Observational
50,000
Beijing
2023-04-25
Recruiting
XuanwuH Acute Ischemic Stroke Registry
NCT05208203Acute Ischemic Stroke
Xuanwu Hospital, Beijing
Observational
500
Beijing
2021-05-01
Rows per page Showing 1–6 of 6
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 6 of those studies with a site in Beijing that also match the filters currently applied.

How many clinical trials are recruiting in Beijing?

6 of the 6 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beijing), 6 studies
PhaseStudiesRecruitingShare
Observational2233.3%
Phase 42233.3%
Not applicable1116.7%
Phase 31116.7%

Most active sponsors

Lead sponsors with the most studies (Beijing)
Lead sponsorStudiesRecruiting
Xuanwu Hospital, Beijing66
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.